{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:58:59Z","timestamp":1788969539377,"version":"build-2803163510"},"reference-count":56,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.2169\/internalmedicine.3727-19","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T22:04:39Z","timestamp":1573164279000},"page":"721-728","source":"Crossref","is-referenced-by-count":19,"title":["Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature"],"prefix":"10.2169","volume":"59","author":[{"given":"Takuya","family":"Suda","sequence":"first","affiliation":[{"name":"Department of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Zoshima","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Takeji","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Mizushima","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Hematology and Immunology, Kanazawa Medical University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akikatsu","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Ishikawa Prefectural Central Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Yachie","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Graduate School of Medical Sciences, Kanazawa University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Kanazawa University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification adult Still&apos;s disease. J Rheumatol 19: 424-430, 1992."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still&apos;s disease. Arthritis Rheum 44: 1716-1717, 2001.","DOI":"10.1002\/1529-0131(200107)44:7<1716::AID-ART298>3.0.CO;2-I"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawashima M, Yamamura M, Tanial M, et al. Levels of interleukin-18 and its biding inhibitor in the blood circulation of patients with adult-onset Still&apos;s disease. Arthritis Rheum 44: 550-560, 2001.","DOI":"10.1002\/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sakata N, Shimizu S, Hirano F, Fushimi K. Epidemiological study of adult-onset Still&apos;s disease using a Japanese administrative database. Rheumatol Int 36: 1399-1405, 2016.","DOI":"10.1007\/s00296-016-3546-8"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Casta\u00f1eda S, Mart\u00ednez-Quintanilla D, Mart\u00edn-Varillas JL, Garc\u00eda-Casta\u00f1eda N, Atienza-Mateo B, Gonz\u00e1ez-Gay MA. Tocilizumab for the treatment of adult-onset Still&apos;s disease. Expert Opin Biol Ther 19: 273-286, 2019.","DOI":"10.1080\/14712598.2019.1590334"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Gerfaud-Valentin M, Jamilloux Y, Iwaz J, S\u00e8ve P. Adult-onset Still&apos;s disease. Autoimmun Rev 13: 708-722, 2014.","DOI":"10.1016\/j.autrev.2014.01.058"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still&apos;s disease. J Autoimmun 93: 24-36, 2018.","DOI":"10.1016\/j.jaut.2018.07.018"},{"key":"8","unstructured":"8. Yamashita S, Furukawa NE, Matsunaga T, Hirakawa Y, Tago M, Yamashita SI. Extremely high serum ferritin: an instrumental marker of masquerading adult-onset Still&apos;s disease with hemophagocytic syndrome. Am J Case Rep 18: 1296-1301, 2017."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kiyonaga Y, Maeshima K, Imada C, Haranaka M, Ishii K, Shibata H. Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still&apos;s disease. Intern Med 53: 1209-1213, 2014.","DOI":"10.2169\/internalmedicine.53.1488"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ichiki H, Shisido M, Nishiyama S. Two cases of adult onset of Still&apos;s disease in the elderly. Nihon Ronen Igakukai Zasshi 29: 960-964, 1992 (in Japanese, Abstract in English).","DOI":"10.3143\/geriatrics.29.960"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still&apos;s disease in a patient over 80 years old successfully treated with low-dose methotrexate therapy. Age Aging 36: 104-106, 2007.","DOI":"10.1093\/ageing\/afl128"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ertuqlul BM, Gencer P, Ozturk B, Saylak Ersoy OM, Sakarya S. Adult-onset Still&apos;s disease in 83-year-old. J Am Geriatr Soc 60: 162-164, 2012.","DOI":"10.1111\/j.1532-5415.2011.03735.x"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Sanada I, Kawano F, Tsukamoto A, Kiyokawa T, Shido T, Koga S. Disseminated intravascular coagulation in a case of adult onset Still&apos;s disease. Rinsho Ketsueki 38: 1194-1198, 1997 (in Japanese, Abstract in English).","DOI":"10.11406\/rinketsu.38.1194"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hamidou MA, Denis M, Barbarot S, Boutoille D, Belizna C, Le Mo\u00ebl G. Usefulness of glycosylated ferritin in atypical presentations of adult onset Still&apos;s disease. Ann Rheum Dis 63: 605, 2004.","DOI":"10.1136\/ard.2003.012484"},{"key":"15","unstructured":"15. Amenomori M, Migita K, Yoshida S, et al. Cytomegalovirus-associated hemophagocystic syndrome in a patient with adult onset Still&apos;s disease. Clin Exp Rheumatol 23: 100-102, 2005."},{"key":"16","unstructured":"16. Shibuya Y, Matuo K, Kawada T, Kosugi T, Gomi T. Adult onset Still&apos;s disease associated esophageal cancer: a case report. Ryumachi 43: 577-582, 2003 (in Japanese, Abstract in English)."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Izumikawa K, Morinaga Y, Kondo A, et al. Adult-Still&apos;s disease associated cytomegalovirus infection. J Infect Chemother 13: 114-117, 2007.","DOI":"10.1007\/s10156-007-0503-1"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Vila LM, Molina MJ. Chronic anemia and thrombocytosis as the initial presentation of Still&apos;s disease in an elderly patient. Gerontology 53: 289-292, 2007.","DOI":"10.1159\/000102949"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kato T, Noguchi K, Uehara M, et al. Angioedema of periorbital region that developed during treatment with etanercept in a case of refractory adult-onset Still&apos;s disease. Intern Med 51: 2801-2804, 2012.","DOI":"10.2169\/internalmedicine.51.8243"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rubenstein EJ. Arkfeld DG. Adult Still&apos;s disease in a 75-year-old patient. J Am Geriatr Soc 52: 2144-2145, 2004.","DOI":"10.1111\/j.1532-5415.2004.52579_5.x"},{"key":"21","unstructured":"21. Tamura K, Kubota K, Kurabayashi H, Take H, Shirakura T. Elderly onset of adult Still&apos;s disease: report of a case. Clin Rheumatol 13: 117-118, 1994."},{"key":"22","unstructured":"22. Kurabayashi H, Kubota K, Tamura K, Shirakura T. Cerebral haemorrhage complicating adult-onset Still&apos;s disease: a case report. J Int Med Res 24: 492-494, 1996."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stoica GS, Cohen RI, Rossoff LJ. Adult Still&apos;s disease and respiratory failure in a 74 year old woman. Postgrad Med J 78: 97-98, 2002.","DOI":"10.1136\/pmj.78.916.97"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Takami A, Nakao S, Miyamori H, et al. Adult-onset Still&apos;s disease with submassive hepatic necrosis. Intern Med 34: 89-91, 1995.","DOI":"10.2169\/internalmedicine.34.89"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Rech J, Ronneberger M, Englbrecht M, et al. Successful treatment of adult-onset Still&apos;s disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Ann Rheum Dis 70: 390-392, 2011.","DOI":"10.1136\/ard.2010.129403"},{"key":"26","unstructured":"26. Uson J, Pena JM, del Arco A, et al. Still&apos;s disease in a 72-year-old man. J Rheumatol 20: 1608-1609, 1993."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Koga T, Tokunaga N, Ichikawa Y, Oizumi K. A 72-year-old female with adult Still&apos;s disease. Inter Med 31: 1356-1358, 1992.","DOI":"10.2169\/internalmedicine.31.1356"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Umeda M, Origuchi T, Fujikawa K, et al. Hemophagocytic syndrome and inflammatory myopathy with abundant macrophages in a patient with adult-onset Still&apos;s disease. Intern Med 53: 2385-2389, 2014.","DOI":"10.2169\/internalmedicine.53.1081"},{"key":"29","unstructured":"29. Watanabe E, Sugawara H, Yamashita T, Ishii A, Oda A, Terai C. Successful tocilizumab therapy for macrophage activation syndrome associated with adult-onset Still&apos;s disease: a cased review. Case Rep Med 2016: 5656320, 2016."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yokoyama M, Suwa A, Shinozawa T, et al. A case of adult onset Still&apos;s disease complicated with adult respiratory distress syndrome and disseminated intravascular coagulation. Nihon Rinsho Meneki Gakkai Kaishi 18: 207-214, 1995 (in Japanese, Abstract in English).","DOI":"10.2177\/jsci.18.207"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Steffe LA, Cooke CL. Still&apos;s disease in a 70-year-old woman. JAMA 249: 2062-2063, 1983.","DOI":"10.1001\/jama.249.15.2062"},{"key":"32","unstructured":"32. Inoue N, Shimizu M, Tsunoda S, Kawano M, Matsumura M, Yachie A. Cytokine profile in adult-onset Still&apos;s disease: comparison with systemic juvenile idiopathic arthritis. Clin Immunol 169: 8-13, 2016."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Ibarra MF, Klein-Gitelman M, Morgan E, et al. Serum neopterin level as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome. Clin Vaccine Immunol 18: 609-614, 2011.","DOI":"10.1128\/CVI.00306-10"},{"key":"34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.13026","volume":"191","author":"M Shimizu","year":"2018","unstructured":"34. Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A. Characteristic elevation of soluble TNF receptor II:I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Clin Exp Immunol 191: 349-355, 2018.","journal-title":"Clinical & Experimental Immunology","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"35","unstructured":"35. Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset still disease: manifestation, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore) 93: 91-99, 2014."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Cagatay Y, Gul A, Cagatay A, et al. Adult-onset Still&apos;s disease. Int J Clin Pract 63: 1050-1055, 2009.","DOI":"10.1111\/j.1742-1241.2007.01393.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Chen PD, Yu SL, Chen S, Weng XH. Retrospective study of 61 patients with adult-onset Still&apos;s disease admitted with fever of unknown origin in China. Clin Rheumatol 31: 175-181, 2012.","DOI":"10.1007\/s10067-011-1798-y"},{"key":"38","unstructured":"38. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still&apos;s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 70: 118-136, 1991."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore) 81: 194-200, 2002.","DOI":"10.1097\/00005792-200205000-00003"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Pay S, T\u00fcrk\u00e7apar N, Kalyoncu M, et al. A multicenter study of patients with adult-onset Still&apos;s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25: 639-644, 2006.","DOI":"10.1007\/s10067-005-0138-5"},{"key":"41","unstructured":"41. Zhu G, Liu G, Liu Y, et al. Liver abnormalities in adult onset Still&apos;s disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol 15: 284-288, 2009."},{"key":"42","unstructured":"42. Kong XD, Xu D, Zhang W, Shi G. Clinical features and prognosis in adult-onset Still&apos;s disease: a study of 104 cases. Clin Rheumatol 29: 1015-1019, 2010."},{"key":"43","unstructured":"43. Colina M, Zucchini W, Ciancio G, Orzincolo C, Trotta F, Govoni M. The evolution of adult-onset Still disease: an observational and comparative study in a cohort of 76 Italian patients. Semin Arthritis Rheum 41: 279-285, 2011."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Asanuma YF, Mimura T, Tsubo H, et al. Nationwide epidemiological survey of 169 patients with adult Still&apos;s disease in Japan. Mod Rheumatol 25: 393-400, 2015.","DOI":"10.3109\/14397595.2014.974881"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Mimura T, Kondo Y, Ohta A, et al. Evidence-based clinical practice guideline for adult Still&apos;s disease. Mod Rheumatol 28: 736-757, 2018.","DOI":"10.1080\/14397595.2018.1465633"},{"key":"46","unstructured":"46. Lenert A, Yao Q. Macrophage activation syndrome complicating adult onset Still&apos;s disease: a single center case series and comparison with literature. Semin Arthritis Rheum 45: 711-716, 2016."},{"key":"47","unstructured":"47. Wakai K, Ohta A, Tamakoshi A, et al. Estimated prevalence and incidence of adult Still&apos;s disease: findings by a nationwide epidemiological survey in Japan. J Epidemiol 7: 221-225, 1997."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ. Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease. J Rheumatol 44: 996-1003, 2017.","DOI":"10.3899\/jrheum.161286"},{"key":"49","unstructured":"49. Ruscitti P, Rago C, Breda L, et al. Macrophage activation syndrome in Still&apos;s disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol 36: 2839-2845, 2017."},{"key":"50","unstructured":"50. Ruscitti P, Cipriani P, Ciccia F, et al. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: analysis of 41 cases collected in 2 rheumatologic centers. Autoimmun Rev 16: 16-21, 2017."},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Fukuoka K, Miyamoto A, Ozawa Y, et al. Adult-onset Still&apos;s disease-like manifestation accompanied by the cancer recurrence after long-term resting state. Mod Rheumatol 29: 704-707, 2019.","DOI":"10.1080\/14397595.2016.1259547"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Hofheinz K, Schett G, Manger B. Adult onset Still&apos;s disease associated with malignancy-cause or coincidence? Semin Arthritis Rheum 45: 621-626, 2016.","DOI":"10.1016\/j.semarthrit.2015.10.003"},{"key":"53","unstructured":"53. Boddaert J, Huong DL, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 83: 348-359, 2004."},{"key":"54","unstructured":"54. Lalani S, Pope J, de Leon F, Peschken C. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. J Rheumatol 37: 38-44, 2010."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Kadavath S, Efthimiou P. Adult-onset Still&apos;s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med 47: 6-14, 2015.","DOI":"10.3109\/07853890.2014.971052"},{"key":"56","unstructured":"56. Wouters JM, van Rijswijk MH, van de Putte LB. Adult onset Still&apos;s disease in the elderly: a report of two cases. J Rheumatol 12: 791-793, 1985."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3727-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T03:21:23Z","timestamp":1583551283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/5\/59_3727-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3727-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}